T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma

Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults with a dismal prognosis. We previously reported that vaccination with heat shock protein peptide complex-96 (HSPPC-96) improves survival in patients with newly diagnosed GBM (NCT02122822). Especially for patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yang, Mudgal, Poorva, Wang, Liuyang, Wu, Haiyang, Huang, Na, Alexander, Peter B., Gao, Zhixian, Ji, Nan, Li, Qi-Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153824/
https://www.ncbi.nlm.nih.gov/pubmed/32313731
http://dx.doi.org/10.1080/2162402X.2020.1749476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153824/
https://www.ncbi.nlm.nih.gov/pubmed/32313731
http://dx.doi.org/10.1080/2162402X.2020.1749476

Ejemplares similares